LDR Holding Corp (NASDAQ: LDRH) and STAAR Surgical (NASDAQ:STAA) are both healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their risk, analyst recommendations, valuation, institutional ownership, earnings, profitability and dividends.

Risk & Volatility

LDR Holding Corp has a beta of 1.11, indicating that its share price is 11% more volatile than the S&P 500. Comparatively, STAAR Surgical has a beta of 1.1, indicating that its share price is 10% more volatile than the S&P 500.

Analyst Recommendations

This is a summary of current recommendations and price targets for LDR Holding Corp and STAAR Surgical, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
LDR Holding Corp 0 0 0 0 N/A
STAAR Surgical 0 0 2 0 3.00

STAAR Surgical has a consensus target price of $15.00, indicating a potential upside of 13.21%. Given STAAR Surgical’s higher probable upside, analysts plainly believe STAAR Surgical is more favorable than LDR Holding Corp.

Profitability

This table compares LDR Holding Corp and STAAR Surgical’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
LDR Holding Corp -18.02% -16.37% -13.65%
STAAR Surgical -6.06% -8.69% -5.03%

Earnings & Valuation

This table compares LDR Holding Corp and STAAR Surgical’s revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio EBITDA Earnings Per Share Price/Earnings Ratio
LDR Holding Corp N/A N/A N/A ($0.71) -52.08
STAAR Surgical $84.48 million 6.45 -$672,999.00 ($0.11) -120.45

LDR Holding Corp has higher revenue, but lower earnings than STAAR Surgical. STAAR Surgical is trading at a lower price-to-earnings ratio than LDR Holding Corp, indicating that it is currently the more affordable of the two stocks.

Insider & Institutional Ownership

76.7% of STAAR Surgical shares are owned by institutional investors. 5.6% of STAAR Surgical shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Summary

STAAR Surgical beats LDR Holding Corp on 9 of the 10 factors compared between the two stocks.

About LDR Holding Corp

LDR Holding Corporation is a medical device company. The Company focuses on designing and commercializing surgical technologies for the treatment of patients suffering from spine disorders. The Company’s primary products are based on its VerteBRIDGE fusion and Mobi non-fusion platforms, both of which are designed for applications in the cervical and lumbar spine. The Company’s VerteBRIDGE products are designed around its plating technology that enables surgeons to implant VerteBRIDGE devices with direct visualization of the disc and to affix the devices to the vertebrae from inside the spinal disc space. The Company’s Mobi non-fusion platform is underlined by Mobi-C, a cervical disc replacement device with a mobile bearing core that is designed to replicate the natural anatomical movement of the spine by facilitating independent bending and twisting similar to a healthy disc. The Company’s traditional fusion products include Easyspine, MC+, ROI, ROI-T, SpineTune and C-Plate.

About STAAR Surgical

STAAR Surgical Company designs, develops, manufactures and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. It operates in the ophthalmic surgical market segment. Its principal products are intraocular lenses used in cataract surgery and implantable collamer lenses used in refractive surgery. It makes lenses used across the world in corrective or refractive surgery, and makes lenses for use in surgery that treats cataracts. Its refractive surgery corrects the types of visual disorders that glasses or contact lenses have treated (myopia, hyperopia, astigmatism and presbyopia). Its refractive surgery corrects the types of visual disorders that glasses or contact lenses have treated (myopia, hyperopia, astigmatism and presbyopia). As of December 30, 2016, it sold its products in more than 60 countries, with direct distribution in the United States, Canada, Japan and Spain, and independent distribution in the remainder of the world.

Receive News & Ratings for LDR Holding Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LDR Holding Corp and related companies with MarketBeat.com's FREE daily email newsletter.